CVS officials say Sovaldi pricing in line with history, but unsustainable

July 21, 2014 5:25 PM

11 0

CVS officials say Sovaldi pricing in line with history, but unsustainable

July 20, 2014, 3:36 PM ET

Gilead Sciences’ controversial $1,000-a-day Sovaldi pill is priced in line with previous treatments for Hepatitis C, but the nation’s health-care system likely won’t be able to handle that kind of sticker shock, and competition probably will bring down that price tag in coming months and years.

Also read: What Is Glioblastoma? McCain’s Brain Tumor Is an Aggressive Type of Cancer

Read more

To category page

Loading...